UBS Initiates Coverage On Tectonic Therapeutic with Neutral Rating, Announces Price Target of $26

UBS analyst Alice Nettleton initiates coverage on Tectonic Therapeutic (NASDAQ:TECX) with a Neutral rating and announces Price Target of $26.